Literature DB >> 31658962

Simultaneous Infection with Enterobacteriaceae and Pseudomonas aeruginosa Harboring Multiple Carbapenemases in a Returning Traveler Colonized with Candida auris.

Ayesha Khan1,2,3, William C Shropshire1,4, Blake Hanson1,5,4, An Q Dinh1,5, Audrey Wanger1,5,6, Luis Ostrosky-Zeichner1,5, Cesar A Arias7,3,5,4,8, William R Miller7,5.   

Abstract

We report our clinical experience treating a critically ill patient with polymicrobial infections due to multidrug-resistant Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa in a 56-year-old woman who received health care in India and was also colonized by Candida auris A precision medicine approach using whole-genome sequencing revealed a multiplicity of mobile elements associated with NDM-1, NDM-5, and OXA-181 and, supplemented with susceptibility testing, guided the selection of rational antimicrobial therapy.
Copyright © 2020 American Society for Microbiology.

Entities:  

Keywords:  Candida auris; Enterobacteriaceae; NDM; Pseudomonas aeruginosa; carbapenemase; polymicrobial infection

Mesh：

Substances：

Year:  2020        PMID： 31658962      PMCID： PMC6985746          DOI： 10.1128/AAC.01466-19

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  19 in total

1.  Activity of plazomicin compared with other aminoglycosides against isolates from European and adjacent countries, including Enterobacteriaceae molecularly characterized for aminoglycoside-modifying enzymes and other resistance mechanisms.

Authors:  Mariana Castanheira; Lalitagauri M Deshpande; Leah N Woosley; Alisa W Serio; Kevin M Krause; Robert K Flamm
Journal:  J Antimicrob Chemother       Date:  2018-12-01       Impact factor: 5.790

2.  Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance.

Authors:  A-P Magiorakos; A Srinivasan; R B Carey; Y Carmeli; M E Falagas; C G Giske; S Harbarth; J F Hindler; G Kahlmeter; B Olsson-Liljequist; D L Paterson; L B Rice; J Stelling; M J Struelens; A Vatopoulos; J T Weber; D L Monnet
Journal:  Clin Microbiol Infect       Date:  2011-07-27       Impact factor: 8.067

3.  Application of "Precision Medicine" Through the Molecular Characterization of Extensively Drug-Resistant Klebsiella pneumoniae in a Multivisceral Transplant Patient.

Authors:  Rossana Rosa; Susan D Rudin; Laura J Rojas; Armando Perez-Cardona; Laura Aragon; David P Nicolau; Federico Perez; Andrea M Hujer; Akin Tekin; Octavio Martinez; Jose F Camargo; Robert A Bonomo; Lilian M Abbo
Journal:  Clin Infect Dis       Date:  2017-08-15       Impact factor: 9.079

4.  Emergence of NDM-5-producing Escherichia coli sequence type 167 clone in Italy.

Authors:  Maria Giufrè; Giulia Errico; Marisa Accogli; Monica Monaco; Laura Villa; Maria Antonietta Distasi; Tito Del Gaudio; Annalisa Pantosti; Alessandra Carattoli; Marina Cerquetti
Journal:  Int J Antimicrob Agents       Date:  2018-02-28       Impact factor: 5.283

5.  Population pharmacokinetics of colistin methanesulfonate and formed colistin in critically ill patients from a multicenter study provide dosing suggestions for various categories of patients.

Authors:  S M Garonzik; J Li; V Thamlikitkul; D L Paterson; S Shoham; J Jacob; F P Silveira; A Forrest; R L Nation
Journal:  Antimicrob Agents Chemother       Date:  2011-05-09       Impact factor: 5.191

6.  Multihospital Occurrence of Pan-Resistant Klebsiella pneumoniae Sequence Type 147 with an ISEcp1-Directed blaOXA-181 Insertion in the mgrB Gene in the United Arab Emirates.

Authors:  Ágnes Sonnevend; Akela Ghazawi; Rayhan Hashmey; Aliasgher Haidermota; Safinaz Girgis; Mubarak Alfaresi; Mohammed Omar; David L Paterson; Hosam M Zowawi; Tibor Pál
Journal:  Antimicrob Agents Chemother       Date:  2017-06-27       Impact factor: 5.191

Review 7.  The Problem of Carbapenemase-Producing-Carbapenem-Resistant-Enterobacteriaceae Detection.

Authors:  Joseph D Lutgring; Brandi M Limbago
Journal:  J Clin Microbiol       Date:  2016-01-06       Impact factor: 5.948

8.  Prevalence and molecular characterisation of New Delhi metallo-β-lactamases NDM-1, NDM-5, NDM-6 and NDM-7 in multidrug-resistant Enterobacteriaceae from India.

Authors:  Mohibur Rahman; Sanket Kumar Shukla; Kashi Nath Prasad; Cristina M Ovejero; Binod Kumar Pati; Aparna Tripathi; Avinash Singh; Ashwini K Srivastava; Bruno Gonzalez-Zorn
Journal:  Int J Antimicrob Agents       Date:  2014-04-24       Impact factor: 5.283

9.  Control of Carbapenem-resistant Enterobacteriaceae, Acinetobacter baumannii, and Pseudomonas aeruginosa in Healthcare Facilities: A Systematic Review and Reanalysis of Quasi-experimental Studies.

Authors:  Sara Tomczyk; Veronica Zanichelli; M Lindsay Grayson; Anthony Twyman; Mohamed Abbas; Daniela Pires; Benedetta Allegranzi; Stephan Harbarth
Journal:  Clin Infect Dis       Date:  2019-02-15       Impact factor: 9.079

10.  blaNDM-5-Bearing IncFII-Type Plasmids of Klebsiella pneumoniae Sequence Type 147 Transmitted by Cross-Border Transfer of a Patient.

Authors:  Juyoun Shin; Jin Yang Baek; Sun Young Cho; Hee Jae Huh; Nam Yong Lee; Jae-Hoon Song; Doo Ryeon Chung; Kwan Soo Ko
Journal:  Antimicrob Agents Chemother       Date:  2016-01-11       Impact factor: 5.191
View more
  6 in total

1.  Precision Medicine and Mysteries in Clinical Microbiology: Rationalizing Epidemiology, Genotype, and Phenotype To Guide Therapeutics.

Authors:  Federico Perez; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2020-01-27       Impact factor: 5.191

Review 2.  The Role of Colistin in the Era of New β-Lactam/β-Lactamase Inhibitor Combinations.

Authors:  Abdullah Tarık Aslan; Murat Akova
Journal:  Antibiotics (Basel)       Date:  2022-02-20

3.  Prevalence of Candida auris in Canadian acute care hospitals among at-risk patients, 2018.

Authors:  Hector Felipe Garcia-Jeldes; Robyn Mitchell; Allison McGeer; Wallis Rudnick; Kanchana Amaratunga; Snigdha Vallabhaneni; Shawn R Lockhart; Amrita Bharat
Journal:  Antimicrob Resist Infect Control       Date:  2020-06-10       Impact factor: 4.887

4.  Comprehensive genome data analysis establishes a triple whammy of carbapenemases, ICEs and multiple clinically relevant bacteria.

Authors:  João Botelho; Joana Mourão; Adam P Roberts; Luísa Peixe
Journal:  Microb Genom       Date:  2020-10

5.  Epidemiology, Molecular Characteristics, and Virulence Factors of Carbapenem-Resistant Pseudomonas aeruginosa Isolated from Patients with Urinary Tract Infections.

Authors:  Yumi Park; Sun Hoe Koo
Journal:  Infect Drug Resist       Date:  2022-01-14       Impact factor: 4.003

6.  Evaluation of Susceptibility Testing Methods for Aztreonam and Ceftazidime-Avibactam Combination Therapy on Extensively Drug-Resistant Gram-Negative Organisms.

Authors:  Ayesha Khan; Samuel G Erickson; Cedric Pettaway; Cesar A Arias; William R Miller; Micah M Bhatti
Journal:  Antimicrob Agents Chemother       Date:  2021-08-23       Impact factor: 5.191
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.